Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950170-25-108990
Filing Date
2025-08-14
Accepted
2025-08-14 16:34:04
Documents
5

Document Format Files

Seq Description Document Type Size
1 425 rkda-425-8k-q225_earning.htm 425 51766
2 EX-99.1 rkda-ex99_1.htm EX-99.1 77699
3 EX-99.2 rkda-ex99_2.htm EX-99.2 450720
4 GRAPHIC img192114479_0.jpg GRAPHIC 9353
5 GRAPHIC img193038000_0.jpg GRAPHIC 9353
  Complete submission text file 0000950170-25-108990.txt   607922
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filed by) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)

Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Subject) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37383 | Film No.: 251220077
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)